eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1774, Poster Board= SUN-050

Richard Lafayette Poster Presenter